Pharmachem Lauds Low Carb Research

KEARNY, N.J.—Pharmachem issued a statement regarding a study published in the July 17 New England Journal of Medicine regarding the efficacy of a low carb diet in weight loss efforts.

“This is a landmark study in that it shows a ‘low carb’ diet should be part of a healthy lifestyle and not just a fad,” says Mitch Skop, director of new product development for Pharmachem, the manufacturer of Phase 2 Carb Controller, an ingredient extracted from the white bean. “Phase 2 is a perfect addition to any product and lifestyle geared towards restricting carbohydrate intake because it has been shown to delay the digestion and absorption of carbs.”

In 2007, Pharmachem’s Phase 2 Carb Controller® received two FDA-permitted structure/function claims.